BlackRock’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Other funds holding ANVS
VCM
VFT
MFG
BlackRock's ANVS Position: Q1 2026 in Review
BlackRock held its Annovis Bio (ANVS) position steady in Q1 2026 at 139,533 shares worth $311K. The position accounts for ﹤0.01% of the portfolio, ranked #4640.
BlackRock first reported a position in ANVS in Q2 2021 and has held it in 20 quarters since. The position peaked at $8.64M in Q2 2021. 56 funds tracked by Wall St. Rank hold ANVS as of Q1 2026.
- BlackRock held 139,533 shares of Annovis Bio worth $311K as of Q1 2026.
- BlackRock left its Annovis Bio share count unchanged in Q1 2026.
- Annovis Bio made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #4640 holding.
- BlackRock first reported a position in Annovis Bio in Q2 2021 and has held it in 20 quarters since.
- BlackRock's Annovis Bio position peaked at $8.64M in Q2 2021.
- 56 funds tracked by Wall St. Rank held Annovis Bio as of Q1 2026.
Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.